Shalby Limited (NSE:SHALBY)
| Market Cap | 18.45B |
| Revenue (ttm) | 11.22B |
| Net Income (ttm) | 44.77M |
| Shares Out | 107.41M |
| EPS (ttm) | 0.36 |
| PE Ratio | 412.02 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,725 |
| Average Volume | 106,074 |
| Open | 174.29 |
| Previous Close | 171.73 |
| Day's Range | 170.81 - 174.29 |
| 52-Week Range | 167.10 - 274.70 |
| Beta | 0.54 |
| RSI | 24.83 |
| Earnings Date | Feb 12, 2026 |
About Shalby
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dent... [Read more]
Financial Performance
In 2024, Shalby's revenue was 10.87 billion, an increase of 16.41% compared to the previous year's 9.34 billion. Earnings were 62.22 million, a decrease of -92.60%.
Financial StatementsNews
Shalby Ltd (BOM:540797) Q2 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges
Shalby Ltd (BOM:540797) Q2 2026 Earnings Call Highlights: Navigating Growth Amidst Challenges
Q2 2026 Shalby Ltd Earnings Call Transcript
Q2 2026 Shalby Ltd Earnings Call Transcript
Shalby signs MoU with Bhartiya Skill Development University to launch B.Voc programs in healthcare
Shalby Ltd., through its academic arm Shalby Academy, has announced a new partnership with Bhartiya Skill Development University (BSDU), Jaipur to jointly launch Bachelor of Vocation (B.Voc.) programs...
Shalby shares drop over 2% as Q1 net profit falls 43% YoY to Rs 8.9 crore, Ebitda down 8% YoY
Shalby shares witnessed a decline of over 2% in early trading after the company reported its Q1 results, reflecting a mixed performance in the first quarter of the year. As of 10:11 AM, the shares wer...
Q3 2025 Shalby Ltd Earnings Call Transcript
Q3 2025 Shalby Ltd Earnings Call Transcript
Shalby shares drop 4% as EBITDA falls 20.1% YoY in Q3
Shalby Ltd. saw a 4% decline in its stock price following the release of its Q3 results. AS of 10:53 AM, the shares were trading 4.57% lower at Rs 208.81. The company reported a revenue growth of 27.6...
Shalby shares jump 3% after FDA approval for Duraniom knee replacement device
Shalby’s stock jumped 3% following the announcement that its U.S. subsidiary, Shalby Advanced Technologies (SAT) Inc., received FDA 510(k) Premarket Notification Clearance for its Duraniom™ knee repla...
Monogram Technologies announces strategic collaboration with Shalby Limited
Monogram Technologies partners with Shalby Limited for multicenter clinical trial on mBȏs TKA System.